For health professionals

NPS MedicineWise is working with the Australian Government Department of Health to provide information and phone line support as COVID-19 vaccines are administered across Australia.

From 1 October 2021 access to nicotine vaping products will require a prescription.

Medicinal cannabis products are treated and regulated as medicines in Australia. Find out more about prescribing, dispensing and taking them.

In 2013, COPD was the fifth leading cause of death in Australia. This program reviews the role of spirometry in diagnosis, and the stepwise management of COPD. 

Opioid medicines in chronic non-cancer pain – balancing opioid-related harm with effective pain management and quality of life

Finding a balance between when to test, what to test and how to treat

Anxiety disorders are common, but there are effective treatments

Providing reassurance, encouraging activity and reducing reliance on imaging

Gastro-oesophageal reflux disease (GORD) is common and often treated successfully with proton pump inhibitors (PPIs). Guidelines recommend trying to step down or stop these medicines once symptoms are controlled.

Rheumatoid arthritis affects around 2% of Australians, and has major effects on quality of life. Find out more about its diagnosis and management.

Neuropathic pain is caused by a lesion or disease of the somatosensory nervous system. Find out more about accurate diagnosis and optimal management of this challenging condition.

Like warfarin, non-vitamin K antagonist oral anticoagulants (NOACs) are no longer ‘new’. Knowing similarities and differences between anticoagulants is key to their safe and effective use. 

This page gathers NPS MedicineWise's resources on abdominal imaging. 

This program offers practical tools and strategies to improve quality of life for patients with osteoarthritis

Codeine is  only available on prescription in Australia from 1 February 2018. Find out more about how health professionals and consumers can manage pain without over-the-counter codeine. 

This program reinforces the role of absolute cardiovascular risk assessment and provides tools and resources to address suspected statin-associated muscle symptoms.

Antibiotic resistance is an urgent global health issue. This program aims to reduce the inappropriate use of antibiotics in the community.

Ankle and knee sprains can be accurately diagnosed without imaging in most cases. This program reviews diagnosis and management of these injuries.

Diabetes is progressive and patients eventually need more than one medicine to maintain blood glucose control. This program reviews the evidence on sulfonylureas and other agents.

Depression is a common problem in primary care. This program reviews a range of approaches to the management of depression.

High BP is the most frequently managed problem in Australian general practice. This program examined its management as a factor in absolute cardiovascular risk.

Osteoporosis is under-recognised and undertreated in Australia. This program examines targeted investigation and treatment.

Chronic pain is a major cause of distress and disability in the community. This program outlines best practice in the use of medicines and non-pharmacological strategies to manage pain.